BICO Group ABCLLKF -7.36%66 Days Inventory is 115.51 as of Mar. 2026, which is 55% below its 10-year median of 259.20. GuruFocus rates CLLKF with a GF Score™ of 66/100 and a GF Value™ of $3.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, BICO Group AB ranks better than 77.64% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). BICO Group AB's Average Total Inventories for the
three
months ended in Mar. 2026 was $20.6 Mil. BICO Group AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $16.2 Mil.
Hence, BICO Group AB's Days Inventory for the
three
months ended in Mar. 2026 was 115.51.
The historical rank and industry rank for BICO Group AB's Days Inventory or its related term are showing as below:
CLLKF'
s Days Inventory Range Over the Past 10 Years
Min: 110.47 Med: 259.2 Max: 2687.09
Current: 110.47
During the past 10 years, BICO Group AB's highest Days Inventory was 2687.09. The lowest was 110.47. And the median was 259.20.
CLLKF's Days Inventory is ranked better than 77.64% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.73
vs CLLKF: 110.47
BICO Group AB's Days Inventory
declined
from Mar. 2025 (152.99) to Mar. 2026 (115.51).
Inventory Turnover measures how fast the company turns over its inventory within a year.
BICO Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BICO Group AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.58.
BICO Group AB (OTCPK:CLLKF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BICO Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BICO Group AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BICO Group AB Days Inventory Related Terms
BICO Group AB Days Inventory Historical Data
* Premium members only.
The historical data trend for BICO Group AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BICO Group AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where BICO Group AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BICO Group AB (CLLKF) has a Days Inventory of 115.51 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BICO Group AB and its competitors. This is 55% below median its historical median of 259.20. Over the past decade, BICO Group AB's Days Inventory has ranged from 110.47 to 2,687.09. According to the industry distribution chart, BICO Group AB ranks #176 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 22.4%.
Is BICO Group AB's Days Inventory too high?
BICO Group AB's current Days Inventory of 115.51 is 55% below median its 10-year median of 259.20. Over the past 10 years, this metric has ranged from a low of 110.47 to a high of 2,687.09. The Medical Devices & Instruments industry median Days Inventory is 179.73. BICO Group AB's value of 115.51 is 35.7% below this industry median. Based on the distribution chart, BICO Group AB ranks #176 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BICO Group AB has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #176 out of 787 companies for Days Inventory. This places BICO Group AB in the top 22% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.73. BICO Group AB's value of 115.51 is 35.7% below this benchmark. Historically, BICO Group AB's own Days Inventory has ranged from 110.47 to 2,687.09 over the past decade. While the company's 10-year median is 259.20 vs. the industry median of 179.73, BICO Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.73, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BICO Group AB's current Days Inventory of 115.51 is 35.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BICO Group AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BICO Group AB's current Days Inventory is 115.51, which is 55% below median its own 10-year median of 259.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.32, compared to a current price of $1.76 — trading 46.9% below its estimated fair value. The current Days Inventory is 115.51, which is 55% below median its 10-year median of 259.20 and 35.7% below the Medical Devices & Instruments industry median of 179.73. BICO Group AB's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current Days Inventory is 115.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CLLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of $1.76 is trading 46.9% below its estimated GF Value™ of $3.32.
GuruFocus considers BICO Group AB to be Possible Value Trap.
Key valuation signals for CLLKF:
Days Inventory: 115.51 (55% below median its 10-year median of 259.20)
GF Value™: $3.32 vs. price of $1.76 (46.9% below fair value)
Industry Position: 35.7% below the Medical Devices & Instruments median (#176 of 787)
No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
66GF Score
Get the complete analysis for CLLKF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLLKF has been successfully added to your 
